A dose response evaluation of delta-1-testololactone in advanced breast cancer

Cancer. 1974 Jan;33(1):9-13. doi: 10.1002/1097-0142(197401)33:1<9::aid-cncr2820330104>3.0.co;2-#.
No abstract available

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / therapy
  • Castration
  • Dose-Response Relationship, Drug
  • Evaluation Studies as Topic
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Neoplasm Metastasis
  • Ovary
  • Palliative Care
  • Prospective Studies
  • Remission, Spontaneous
  • Testolactone / administration & dosage*
  • Testolactone / adverse effects
  • Testolactone / therapeutic use

Substances

  • Testolactone